Therefore, in tumors with HIF1 overexpression or overactivation, vitamin C treatment may increase the activity of HIF hydroxylases, with consequent HIF1α degradation and inhibition of the tumor promoting effects of this transcription factor [18,127,128,129,130]. This evidence concerns the gene HIF1A and neoplasm.